ESRP1 was shown to induce G1-phase cell cycle arrest and suppress cell proliferation in cervical cancer cells by decreasing cyclin A2 mRNA stability through the direct binding to the 3’ UTR of cyclin A2 [53]. Here, ESRP1 is linked to cervical carcinoma.